US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist
  • 9.160
  • +0.130+1.44%
Close May 24 16:00 ET
  • 9.160
  • 0.0000.00%
Post 19:58 ET
2.18BMarket Cap-5619P/E (TTM)

Recursion Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
-65.04%-54.54M
-83.11%-61.62M
Net income from continuing operations
-39.87%-91.37M
-36.99%-328.07M
-61.75%-93M
-53.89%-93.02M
-17.03%-76.73M
-16.70%-65.33M
-28.42%-239.48M
11.46%-57.49M
-27.45%-60.45M
-51.06%-65.56M
Depreciation and amortization
97.88%7.38M
107.57%24.4M
135.00%7.55M
153.53%7.58M
98.96%5.54M
34.73%3.73M
39.87%11.76M
43.74%3.21M
22.70%2.99M
19.52%2.79M
Other non cash items
-29.29%1.91M
33.76%11.45M
168.88%6.55M
-90.41%170K
-8.20%2.03M
26.12%2.7M
108.93%8.56M
110.54%2.44M
282.11%1.77M
99.37%2.21M
Change In working capital
-49.36%-36.45M
-147.90%-50.26M
-1,775.21%-11.27M
42.54%-4.46M
-6.12%-10.12M
-119.87%-24.4M
34,387.91%104.92M
84.82%-601K
-206.52%-7.77M
-1,060.42%-9.54M
-Change in receivables
-228.08%-1.04M
-387,700.00%-7.76M
-215.25%-6.42M
-105.37%-203K
54.78%-814K
95.80%-317K
99.96%-2K
306.72%5.57M
186.15%3.78M
-484.62%-1.8M
-Change in payables and accrued expense
-88.89%-17.96M
392.53%8.44M
-50.65%4.78M
131.91%8.41M
207.30%4.76M
27.67%-9.51M
-88.63%1.71M
442.35%9.69M
-74.42%3.63M
-48.83%1.55M
-Change in other current liabilities
-55.24%-3.79M
-38.71%-9.86M
12.41%-1.91M
-18.58%-2.51M
-93.79%-3M
-93.20%-2.44M
---7.11M
---2.18M
---2.12M
---1.55M
-Change in other working capital
-12.54%-13.66M
-137.23%-41.08M
43.58%-7.72M
22.16%-10.16M
-43.01%-11.07M
-108.38%-12.13M
1,203.20%110.32M
-447.00%-13.68M
-422.12%-13.05M
-209.52%-7.74M
Cash from discontinued investing activities
Operating cash flow
-39.53%-102.3M
-244.55%-287.78M
-65.54%-74.08M
-33.70%-72.92M
-9.48%-67.47M
-194.74%-73.32M
47.34%-83.52M
26.83%-44.75M
-65.04%-54.54M
-83.11%-61.62M
Investing cash flow
Cash flow from continuing investing activities
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
127.33%52.98M
179.52%4.94M
Net PPE purchase and sale
-28.56%-6.65M
67.74%-11.96M
74.09%-2.07M
90.98%-745K
75.92%-3.97M
-19.18%-5.18M
6.88%-37.06M
-78.74%-7.98M
14.87%-8.26M
-165.21%-16.48M
Net intangibles purchase and sale
--0
-99.00%-597K
---350K
72.67%-82K
--0
---165K
---300K
--0
---300K
--0
Net business purchase and sale
----
--1.84M
---71K
--0
----
----
--0
--0
--0
----
Net investment purchase and sale
----
-99.79%480K
--0
-99.22%480K
----
----
199.42%230.61M
--0
133.42%61.55M
--21.42M
Cash from discontinued investing activities
Investing cash flow
-24.59%-6.65M
-105.29%-10.23M
68.82%-2.49M
-100.65%-347K
-141.56%-2.05M
-103.73%-5.34M
171.11%193.25M
84.73%-7.98M
127.33%52.98M
179.52%4.94M
Financing cash flow
Cash flow from continuing financing activities
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
121.06%2.34M
-99.42%2.67M
Net issuance payments of debt
-8.33%-26K
-751.11%-766K
-2,917.39%-694K
-4.35%-24K
-9.09%-24K
-9.09%-24K
99.30%-90K
-9.52%-23K
99.82%-23K
-10.00%-22K
Net common stock issuance
--10.87M
-10.87%128.09M
-45.66%78.09M
----
----
--0
-68.95%143.71M
--143.71M
----
----
Proceeds from stock option exercised by employees
56.73%3.05M
19.41%12.81M
-8.63%3.26M
60.55%3.79M
41.67%3.81M
-7.60%1.95M
27.11%10.72M
-6.52%3.57M
43.73%2.36M
226.46%2.69M
Cash from discontinued financing activities
Financing cash flow
623.05%13.9M
-9.21%140.13M
-45.23%80.66M
2,200.60%53.77M
41.94%3.79M
-7.77%1.92M
-66.34%154.35M
3,779.24%147.26M
121.06%2.34M
-99.42%2.67M
Net cash flow
Beginning cash position
-28.20%401.43M
89.31%559.11M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
10.55%295.35M
14.80%464.89M
-27.82%464.11M
136.45%518.13M
Current changes in cash
-23.88%-95.06M
-159.79%-157.88M
-95.67%4.09M
-2,600.26%-19.5M
-21.69%-65.73M
-134.44%-76.73M
837.02%264.07M
186.25%94.53M
100.33%780K
-112.74%-54.02M
Effect of exchange rate changes
-10,850.00%-219K
161.24%188K
140.39%124K
---115K
--181K
---2K
---307K
---307K
--0
--0
End cash Position
-36.53%306.15M
-28.20%401.43M
-28.20%401.43M
-14.56%397.21M
-10.19%416.82M
-6.90%482.38M
89.31%559.11M
89.31%559.11M
14.80%464.89M
-27.82%464.11M
Free cash flow
-38.52%-108.95M
-148.45%-300.33M
-45.08%-76.49M
-16.87%-73.75M
8.53%-71.44M
-207.68%-78.66M
39.07%-120.88M
19.65%-52.73M
-47.60%-63.1M
-95.91%-78.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M-65.04%-54.54M-83.11%-61.62M
Net income from continuing operations -39.87%-91.37M-36.99%-328.07M-61.75%-93M-53.89%-93.02M-17.03%-76.73M-16.70%-65.33M-28.42%-239.48M11.46%-57.49M-27.45%-60.45M-51.06%-65.56M
Depreciation and amortization 97.88%7.38M107.57%24.4M135.00%7.55M153.53%7.58M98.96%5.54M34.73%3.73M39.87%11.76M43.74%3.21M22.70%2.99M19.52%2.79M
Other non cash items -29.29%1.91M33.76%11.45M168.88%6.55M-90.41%170K-8.20%2.03M26.12%2.7M108.93%8.56M110.54%2.44M282.11%1.77M99.37%2.21M
Change In working capital -49.36%-36.45M-147.90%-50.26M-1,775.21%-11.27M42.54%-4.46M-6.12%-10.12M-119.87%-24.4M34,387.91%104.92M84.82%-601K-206.52%-7.77M-1,060.42%-9.54M
-Change in receivables -228.08%-1.04M-387,700.00%-7.76M-215.25%-6.42M-105.37%-203K54.78%-814K95.80%-317K99.96%-2K306.72%5.57M186.15%3.78M-484.62%-1.8M
-Change in payables and accrued expense -88.89%-17.96M392.53%8.44M-50.65%4.78M131.91%8.41M207.30%4.76M27.67%-9.51M-88.63%1.71M442.35%9.69M-74.42%3.63M-48.83%1.55M
-Change in other current liabilities -55.24%-3.79M-38.71%-9.86M12.41%-1.91M-18.58%-2.51M-93.79%-3M-93.20%-2.44M---7.11M---2.18M---2.12M---1.55M
-Change in other working capital -12.54%-13.66M-137.23%-41.08M43.58%-7.72M22.16%-10.16M-43.01%-11.07M-108.38%-12.13M1,203.20%110.32M-447.00%-13.68M-422.12%-13.05M-209.52%-7.74M
Cash from discontinued investing activities
Operating cash flow -39.53%-102.3M-244.55%-287.78M-65.54%-74.08M-33.70%-72.92M-9.48%-67.47M-194.74%-73.32M47.34%-83.52M26.83%-44.75M-65.04%-54.54M-83.11%-61.62M
Investing cash flow
Cash flow from continuing investing activities -24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M127.33%52.98M179.52%4.94M
Net PPE purchase and sale -28.56%-6.65M67.74%-11.96M74.09%-2.07M90.98%-745K75.92%-3.97M-19.18%-5.18M6.88%-37.06M-78.74%-7.98M14.87%-8.26M-165.21%-16.48M
Net intangibles purchase and sale --0-99.00%-597K---350K72.67%-82K--0---165K---300K--0---300K--0
Net business purchase and sale ------1.84M---71K--0----------0--0--0----
Net investment purchase and sale -----99.79%480K--0-99.22%480K--------199.42%230.61M--0133.42%61.55M--21.42M
Cash from discontinued investing activities
Investing cash flow -24.59%-6.65M-105.29%-10.23M68.82%-2.49M-100.65%-347K-141.56%-2.05M-103.73%-5.34M171.11%193.25M84.73%-7.98M127.33%52.98M179.52%4.94M
Financing cash flow
Cash flow from continuing financing activities 623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M121.06%2.34M-99.42%2.67M
Net issuance payments of debt -8.33%-26K-751.11%-766K-2,917.39%-694K-4.35%-24K-9.09%-24K-9.09%-24K99.30%-90K-9.52%-23K99.82%-23K-10.00%-22K
Net common stock issuance --10.87M-10.87%128.09M-45.66%78.09M----------0-68.95%143.71M--143.71M--------
Proceeds from stock option exercised by employees 56.73%3.05M19.41%12.81M-8.63%3.26M60.55%3.79M41.67%3.81M-7.60%1.95M27.11%10.72M-6.52%3.57M43.73%2.36M226.46%2.69M
Cash from discontinued financing activities
Financing cash flow 623.05%13.9M-9.21%140.13M-45.23%80.66M2,200.60%53.77M41.94%3.79M-7.77%1.92M-66.34%154.35M3,779.24%147.26M121.06%2.34M-99.42%2.67M
Net cash flow
Beginning cash position -28.20%401.43M89.31%559.11M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M10.55%295.35M14.80%464.89M-27.82%464.11M136.45%518.13M
Current changes in cash -23.88%-95.06M-159.79%-157.88M-95.67%4.09M-2,600.26%-19.5M-21.69%-65.73M-134.44%-76.73M837.02%264.07M186.25%94.53M100.33%780K-112.74%-54.02M
Effect of exchange rate changes -10,850.00%-219K161.24%188K140.39%124K---115K--181K---2K---307K---307K--0--0
End cash Position -36.53%306.15M-28.20%401.43M-28.20%401.43M-14.56%397.21M-10.19%416.82M-6.90%482.38M89.31%559.11M89.31%559.11M14.80%464.89M-27.82%464.11M
Free cash flow -38.52%-108.95M-148.45%-300.33M-45.08%-76.49M-16.87%-73.75M8.53%-71.44M-207.68%-78.66M39.07%-120.88M19.65%-52.73M-47.60%-63.1M-95.91%-78.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg